000			02225 a2200637 4500
005			20250517223851.0
264		0	_c20200421
008			202004s 0 0 eng d
022			_a1873-5010
024	7		_a10.1016/j.jcf.2018.05.013 _2doi
040			_aNLM _beng _cNLM
100	1		_aDarrah, Rebecca J
245	0	0	_aAGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations. _h[electronic resource]
260			_bJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _c01 2019
300			_a127-134 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAngiotensin II Type 2 Receptor Blockers _xpharmacology
650	0	4	_aAnimals
650	0	4	_aChild
650	0	4	_aCystic Fibrosis _xcomplications
650	0	4	_aDNA _xgenetics
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aForced Expiratory Flow Rates _xphysiology
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aLung _xphysiopathology
650	0	4	_aLung Diseases _xetiology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMutation
650	0	4	_aPyridines _xpharmacology
650	0	4	_aReceptor, Angiotensin, Type 2 _xdrug effects
650	0	4	_aRetrospective Studies
700	1		_aJacono, Frank J
700	1		_aJoshi, Neha
700	1		_aMitchell, Anna L
700	1		_aSattar, Abdus
700	1		_aCampanaro, Cara K
700	1		_aLitman, Paul
700	1		_aFrey, Jennifer
700	1		_aNethery, David E
700	1		_aBarbato, Eric S
700	1		_aHodges, Craig A
700	1		_aCorvol, Harriet
700	1		_aCutting, Garry R
700	1		_aKnowles, Michael R
700	1		_aStrug, Lisa J
700	1		_aDrumm, Mitchell L
773	0		_tJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _gvol. 18 _gno. 1 _gp. 127-134
856	4	0	_uhttps://doi.org/10.1016/j.jcf.2018.05.013 _zAvailable from publisher's website
999			_c28564357 _d28564357